GlassScriptPhysician profile
Cassandra P Desmet
NPI 1851786388
$3,390.02
in general payments reported to CMS, 2019-2025
33 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $774 · 2023: $1,355 · 2024: $851 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,526 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,525.70 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,124.81 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Mylan Specialty L.P. | $340.29 | 2022-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $293.90 | 2022-2024 | Dupixent |
| Integra Lifesciences Corporation | $174.58 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $131.61 | 2022-2023 | Belsomra, Verquvo, Steglatro |
| Abbvie INC. | $117.47 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.02 | 2023-2024 | Ofev |
| Baxter Healthcare | $111.58 | 2022-2023 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $111.05 | 2023-2024 | (Ak6) Vest Therapy |
| Astrazeneca Pharmaceuticals LP | $105.25 | 2022-2024 | Tezspire, Fasenra, Breztri |
| Genzyme Corporation | $98.06 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $89.99 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $69.64 | 2022 | |
| United Therapeutics Corporation | $61.62 | 2023-2024 | Tyvaso |
| Grifols USA, LLC | $50.47 | 2022-2023 | Prolastin-C Liquid |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $49.34 | 2023 | Wegovy |
| Insmed, INC. | $48.86 | 2024 | Arikayce |
| Alexion Pharmaceuticals, INC. | $32.47 | 2023 | Ultomiris |
| Harmony Biosciences LLC | $29.55 | 2022 | |
| Electromed, INC. | $26.97 | 2022 | |
| Pulmonx Corporation | $21.53 | 2022 | |
| Pfizer INC. | $17.48 | 2023 | |
| Idorsia Pharmaceuticals US INC | $16.81 | 2023 | Quviviq |
| Smith+Nephew, INC. | $16.66 | 2025 | Collagenase Santyl |
| Actelion Pharmaceuticals US, INC. | $16.42 | 2023 | Opsumit |
| Inspire Medical Systems, INC. | $16.29 | 2023 | Inspire |
| Axsome Therapeutics, INC. | $15.82 | 2023 | Sunosi |
| Inogen, INC. | $14.89 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Gilead Sciences, INC. | $14.88 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.87 | 2022 | |
| Covis Pharma Gmbh | $14.84 | 2023 | |
| Mallinckrodt Hospital Products INC. | $13.86 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Desmet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.